Work

THU0191 Novel formulation of ct-p13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial

Year: 2018

Type: article

Study design: Clinical Trial

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2018-eular.1810

Authors: R. Westhovens, D.H. Yoo, J. Jaworski, E. Matyska-Piekarska, S. Smiyan, D. Ivanova, A. Zielinska, E.-K. Raussi, A. Batalov, S.J. Lee, S.Y. Lee, J.H. Suh

Institutions: KU Leuven, Hanyang University Seoul Hospital, Hanyang University Hospital for Rheumatic Disease, I.Horbachevsky Ternopil National Medical University, North Estonia Medical Centre, Medical University Plovdiv, Celltrion (South Korea)

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2908872136

FWCI: 1.244

Cites:

Cited by: 17

Related to: 10